X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-02 | CVS | Ludwig Edward J | Dir | P - Purchase | $53.88 | +1,000 | 32,709 | +3% | +$53,879 | |||||
2024-05-02 | CVS | Mahoney Michael F | Dir | P - Purchase | $54.49 | +9,181 | 11,383 | +417% | +$500,294 | ||||||
| D | 2024-02-16 | CVS | Shah Prem S | EVP, Pres-Pharm, Consumer W | S - Sale+OE | $76.95 | -29,473 | 77,553 | -28% | -$2,267,947 | |||||
| D | 2023-11-03 | CVS | Ludwig Edward J | Dir | P - Purchase | $70.47 | +2,000 | 31,709 | +7% | +$140,930 | |||||
| D | 2023-08-03 | CVS | Clark James David | SVP, Cont, Chief Acct Officer | S - Sale+OE | $74.92 | -25,759 | 13,580 | -65% | -$1,930,004 | |||||
| D | 2023-05-03 | CVS | Lynch Karen S | Pres, CEO | P - Purchase | $69.75 | +14,000 | 431,392 | +3% | +$976,567 | |||||
| D | 2022-12-15 | CVS | Moriarty Thomas M | EVP, GC | S - Sale+OE | $98.36 | -137,466 | 814,574 | -14% | -$13,521,180 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |